Neutrophils augment LPS-mediated pro-inflammatory signaling in human lung epithelial cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 7, 2012, Pages 1151-1162

  Boots, Agnes W ^a,b   Gerloff, Kirsten ^a   Bartholomé, Roger ^a   van Berlo, Damien ^a   Ledermann, Kirstin ^a   Haenen, Guido R M M ^b   Bast, Aalt ^b   van Schooten, Frederik Jan ^a   Albrecht, Catrin ^a   Schins, Roel P F ^a  

^a IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

BEAS 2B cell; Interleukin 8; NADPH oxidase; Reactive oxygen species; Synergism

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BRONCHUS MUCOSA; CELL VIABILITY; CHEMOTAXIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOTOXICITY; DISEASE ASSOCIATION; DNA BINDING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL SEPARATION; CHEMOTACTIC FACTORS; DNA; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LUNG; MICE; MODELS, BIOLOGICAL; NADPH OXIDASE; NEUTROPHILS; PHOSPHORYLATION; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

MUS;

EID: 84861334272     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.04.012     Document Type: Article

References (61)

1. Boots A.W., Hristova M., Kasahara D.I., Haenen G.R., Bast A., van der Vliet A. ATP-mediated activation of the NADPH oxidase DUOX1 mediates airway epithelial responses to bacterial stimuli. J. Biol. Chem. 2009, 284:17858-17867.
2. van der Vliet A. NADPH oxidases in lung biology and pathology: host defense enzymes, and more. Free Radic. Biol. Med. 2008, 44:938-955.
3. Bokoch G.M., Diebold B., Kim J.S., Gianni D. Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases. Antioxid. Redox. Signal. 2009, 11:2429-2441.
4. Geiszt M., Witta J., Baffi J., Lekstrom K., Leto T.L. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 2003, 17:1502-1504.
5. Wesley U.V., Bove P.F., Hristova M., McCarthy S., van der Vliet A. Airway epithelial cell migration and wound repair by ATP-mediated activation of dual oxidase 1. J. Biol. Chem. 2007, 282:3213-3220.
6. Forteza R., Salathe M., Miot F., Forteza R., Conner G.E. Regulated hydrogen peroxide production by Duox in human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2005, 32:462-469.
7. Hampton M.B., Kettle A.J., Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase and bacterial killing. Blood 1998, 92:3007-3017.
8. Gerson C., Sabater J., Scuri M., Torbati A., Coffey R., Abraham J.W., Lauredo I., Forteza R., Wanner A., Salathe M., Abraham W.M., Conner G.E. The lactoperoxidase system functions in bacterial clearance of airways. Am. J. Respir. Cell Mol. Biol. 2000, 22:665-671.
9. Haegens A., Vernooy J.H.J., Heeringa P., Mossman B.T., Wouters E.F.M. Myeloperoxidase modulated lung epithelial responses to pro-inflammatory agents. Eur. Respir. J. 2008, 31:252-260.
10. Cheng G., Cao Z., Xu X., van Meir E.G., Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4 and Nox5. Gene 2001, 269:131-140.
11. Mittal M., Roth M., Konig P., Hofmann S., Dony E., Goyal P., Selbitz A.C., Schermuly R.T., Ghofrani H.A., Kwapiszewska G., Kummer W., Klepetko W., Hoda M.A., Fink L., Hanze J., Seeger W., Grimminger F., Schmidt H.H., Weismann N. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ. Res. 2007, 101:258-267.
12. Hecker L., Vittal R., Jones T., Jagirdar R., Luckhardt T.R., Horowitz J.C., Pennathur S., Martinez F.J., Thannickal V.J. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 2009, 15:1077-1081.
13. Chang M.M., Juarez M., Dallas M.H., Wu R. Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280:L107-L115.
14. Nakanaga T., Nadel J.A., Ueki I.F., Koff J.L., Shao M.X. Regulation of interleukin-8 via an airway epithelial signaling cascade. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L1289-L1296.
15. McBride K., Nemer M. The C-terminal domain of c-fos is required for the activation of an AP-1 site specific for jun-fos heterodimers. Mol. Cell. Biol. 1998, 18:5073-5081.
16. Mukaida N., Okamoto S., Ishikawa Y., Matsushima K. Molecular mechanism of interleukin-8 gene expression. J. Leukoc. Biol. 1994, 56:554-558.
17. Khan K., Konar M., Goyal A., Ghosh S. Enteroaggregative Escherichia coli infection induces IL-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappa B and AP-1 in INT-407 cells. Mol. Cell. Biochem. 2010, 337:17-24.
18. Kim Y.M., Reed W., Wu W., Bromberg P.A., Graves L.M., Samet J.M. Zinc-induced IL-8 expression involves AP-1, JNK and ERK activities in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L1028-L1035.
19. Reddy S.P., Mossman B.T. Role and regulation of activator protein-1 in toxicant-induced responses of the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L1161-L1178.
20. May M.J., Ghosh S. Signal transduction through NF-kappa B. Immunol. Today 1998, 19:80-88.
21. Fan J., Frey R.S., Rahman A., Malik A.B. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-alpha -induced NF-kappa B activation and intercellular adhesion molecule-1 expression in endothelial cells. J. Biol. Chem. 2002, 277:3404-3411.
22. Djeu J.Y., Matsushima K., Oppenheim J.J., Shiotsuki K., Blanchard D.K. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J. Immunol. 1990, 144:2205-2210.
23. Jaquet V., Scapozza L., Clark R.A., Krause K.H., Lambeth J.D. Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid. Redox. Signal. 2009, 11:2535-2552.
24. Leto T.L., Morand S., Hurt D., Ueyama T. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid. Redox. Signal. 2009, 11:2607-2619.
25. Gungor N., Knaapen A.M., Peluso M., Haenen G.R.M.M., Chui R.K., Godschalk R.W.L., van Schooten F.J. Genetoxic effects of neutrophils and hypochlorous acid. Mutagenesis 2010, 25:149-154.
26. Knaapen A.M., Seiler F., Schilderman P.A.E.L., Nehls P., Bruch J., Schins R.P.F., Borm P.J.A. Neutrophils cause oxidative DNA damage in alveolar epithelial cells. Free Radic. Biol. Med. 1999, 27:234-240.
27. Gungor N., Godschalk R.W.L., Pachen D.M., van Schooten F.J., Knaapen A.M. Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: role of myeloperoxidase. FASEB J. 2007, 21:2359-2367.
28. Sibille Y., Marchandise F.X. Pulmonary immune cells in health and disease: polymorphonuclear neutrophils. Eur. Respir. J. 1993, 6:1529-1543.
29. Kim S., Nadel J.A. Role of neutrophils in mucus hypersecretion in COPD and implications for therapy. Treat. Respir. Med. 2004, 3:147-159.
30. Jackson S.H., Gallin J.I., Holland S.M. The p47 phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 1995, 182:751-758.
31. Boxio R., Bossenmeyer-Poerie C., Steinckwich N., Dournon C., Nusse O. Mouse bone marrow contains large numbers of functionally competent neutrophils. J. Leukoc. Biol. 2004, 75:604-611.
32. Sha Q., Truong-Tran A.Q., Plitt J.R., Beck L.A., Schleimer R.P. Activation of airway epithelial cells by toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 2004, 31:358-364.
33. Kobayashi Y. The role of chemokines in neutrophil biology. Front. Biosci. 2008, 13:2400-2407.
34. Thorn J. The inflammatory response in humans after inhalation of bacterial endotoxin: a review. Inflamm. Res. 2001, 50:254-261.
35. Laan M., Bozinovski S., Anderson G.P. Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J. Immunol. 2004, 173:4164-4170.
36. Liu K., Anderson G.P., Bozinovski S. DNA vector augments inflammation in epithelial cells via EGFR-dependent regulation of TLR4 and TLR2. Am. J. Respir. Cell Mol. Biol. 2008, 39:305-311.
37. Kobayashi Y. Neutrophil infiltration and chemokines. Crit. Rev. Immunol. 2006, 26:307-316.
38. Tephly L.A., Carter A.B. Constitutive NADPH oxidase and increased mitochondrial respiratory chain activity regulate chemokine gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293:L1143-L1155.
39. Roger T., Out T., Mukaida N., Matsushima K., Jansen H., Lutter R. Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem. J. 1998, 330(Pt 1):429-435.
40. Koller B., Bals R., Roos D., Korting H.C., Griese M., Hartl D. Innate immune receptors on neutrophils and their role in chronic lung disease. Eur. J. Clin. Invest. 2009, 39:535-547.
41. Linden A., Laan M., Anderson G.P. Neutrophils, interleukin-17A and lung disease. Eur. Respir. J. 2005, 25:159-172.
42. Chilakapati J., Wallace K., Ren H., Fricke M., Bailey K., Ward W., Creed J., Kitchin K. Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid. Toxicology 2010, 268:31-39.
43. Knaapen A.M., Schins R.P., Borm P.J., van Schooten F.J. Nitrite enhances neutrophil-induced DNA strand breakage in pulmonary epithelial cells by inhibition of myeloperoxidase. Carcinogenesis 2005, 26:1642-1648.
44. Babior B.M., Kipnes R.S., Curnutte J.T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 1973, 52:741-744.
45. 2-induced proliferation of primary alveolar epithelial cells is mediated by MAP kinases. Antioxid. Redox Signal. 2005, 7:6-13.
46. Moodie F.M., Marwick J.A., Anderson C.S., Szulakowski P., BIswas S.K., Bauter M.R., Kilty I., Rahman I. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kB activation and pro-inflammatory cytokine release in alveolar epithelial cells. FASEB J. 2004, 18:1894-1896.
47. 2-induced alveolar epithelial cell DNA damage: role of MAPK activation and DNA repair. Am. J. Respir. Cell Mol. Biol. 2004, 31:107-113.
48. Rahman I., Gilmour P.S., Jimenez L.A., MacNee W. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol. Cell. Biochem. 2002, 234-235:239-248.
49. Qi S., den Hartog G.J., Bast A. Superoxide radicals increase transforming growth factor-beta1 and collagen release from human lung fibroblasts via cellular influx through chloride channels. Toxicol. Appl. Pharmacol. 2009, 237:111-118.
50. Kunkel S.L., Standford T., Kasahara K., Strieter R.M. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp. Lung Res. 1991, 17:17-23.
51. Antony V.B., Godbey S.W., Kunkel S.L., Hott J.W., Hartman D.L., Burdick M.D., Strieter R.M. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8 and monocyte chemotactic peptide-1 in human pleural fluids. J. Immunol. 1993, 151:7216-7223.
52. Baggiolini M., Walz A., Kunkel S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 1989, 84:1045-1049.
53. Daniels R.H., Finnen M.J., Hill M.E., Lackie J.M. Recombinant human monocyte IL-8 primes NADPH-oxidase and phospholipase A2 activation in human neutrophils. Immunology 1992, 75:157-163.
54. Griffith B., Pendyala S., Hecker L., Lee P.J., Natarajan V., Thannickal V.J. NOX enzymes and pulmonary disease. Antioxid. Redox. Signal. 2009, 11:2505-2516.
55. Holland S.M. Chronic granulomatous disease. Clin. Rev. Allergy Immunol. 2010, 38:3-10.
56. Zhang W.J., Wei H., Frei B. Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivo. Free Radic. Biol. Med. 2009, 46:791-798.
57. Hallett J.M., Leitch A.E., Riley N.A., Duffin R., Haslett C., Rossi A.G. Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. Trends Pharmacol. Sci. 2008, 29:250-257.
58. Kessenbrock K., Fröhlich L., Sixt M., Lämmermann T., Pfister H., Bateman A., Belaaouaj A., Ring J., Ollert M., Fässler R., Jenne D.E. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating anti-inflammatory progranulin. JCI 2008, 118:2438-2447.
59. Cosgrove S., Chotirmall S.H., Greene C.M., McElvaney N.G. Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway. J. Biol. Chem. 2011, 286:7692-7704.
60. Demkow U., van Overveld F.J. Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment. Eur. J. Med. Res. 2010, 15:27-35.
61. Guay C., Laviolette M., Tremblay G.M. Targeting serine proteases in asthma. Curr. Top. Med. Chem. 2006, 6:393-402.